0001209191-11-031297.txt : 20110526 0001209191-11-031297.hdr.sgml : 20110526 20110526164857 ACCESSION NUMBER: 0001209191-11-031297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110525 FILED AS OF DATE: 20110526 DATE AS OF CHANGE: 20110526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER KENNETH S CENTRAL INDEX KEY: 0001046336 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 11874667 MAIL ADDRESS: STREET 1: C/O ECOSCIENCE CORP STREET 2: 10 ALVIN COURT CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-05-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001046336 BOGER KENNETH S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02176 0 1 0 0 SVP & General Counsel Common Stock 2011-05-25 4 S 0 1577 55.56 D 115488 D Common Stock 2011-05-25 4 S 0 2489 56.23 D 112999 D Common Stock 5021 I 401(k) Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $55.56 (range $55.14 to $55.95). Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $56.23 (range $56.01 to $56.46). Kenneth S. Boger 2011-05-26